Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has recently caught the eye of investors with its potential upside of 271.39%, according to analyst projections. This biotechnology company, headquartered..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a trailblazer in the biotechnology sector, has caught the attention of investors with its promising pipeline of cancer therapies and a..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is capturing the attention of investors with its promising pipeline of oncolytic immunotherapies. As the company focuses..
Investors eyeing the biotechnology sector may find Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) an intriguing prospect. With a market capitalization of $2.62 billion, this San Diego-based..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands out in the biotechnology sector with its innovative approach to cell therapy for treating metastatic melanoma and other solid tumor..
InMode Ltd. (NASDAQ: INMD) stands at an intriguing intersection within the healthcare sector, particularly in the medical devices industry, where innovation meets aesthetic demand. Headquartered in..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, is making waves in the biotech industry with its focus on developing therapies for central nervous..
Fulgent Genetics, Inc. (NASDAQ: FLGT) is a prominent player in the healthcare sector, specifically within diagnostics and research. Despite its innovative approach to clinical diagnostics and..
Investors looking for opportunities in the biotechnology sector may find Zymeworks Inc. (NASDAQ: ZYME) an intriguing candidate. With a current market capitalization of $2.04 billion, Zymeworks..
Anavex Life Sciences Corp. (NASDAQ: AVXL) is a small-cap biotechnology company that is drawing attention in the healthcare sector. With a market capitalization of $126.07 million..
Immunome, Inc. (NASDAQ: IMNM) stands as a compelling prospect within the biotechnology sector, capturing investor interest with its robust pipeline and significant potential upside. With a..
GH Research PLC (GHRS) is capturing the attention of investors with its promising portfolio in the biotechnology sector, despite the absence of traditional valuation metrics like..
Nurix Therapeutics, Inc. (NRIX), a dynamic player in the biotechnology sector, is capturing investor attention with its significant potential upside of 35.24%. As a clinical-stage biopharmaceutical..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the biotechnology industry with its innovative approach to genome editing using CRISPR/Cas9 technology. Despite facing a..
Bicara Therapeutics Inc. (NASDAQ: BCAX), a burgeoning player in the biotechnology sector, stands out with a remarkable potential upside of 102.54%, according to the latest analyst..
AMN Healthcare Services Inc (NYSE: AMN) is garnering attention in the healthcare sector with its strategic focus on providing technology-enabled workforce solutions to a variety of..
Nutex Health Inc. (NUTX), a prominent player in the U.S. healthcare sector, is capturing investor attention with its innovative approach to medical care facilities. With a..
Weave Communications, Inc. (NASDAQ: WEAV), a key player in the Health Information Services industry, is steadily capturing the attention of investors with its innovative AI-powered communication..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands out in the healthcare sector as a significant player in the drug manufacturing industry, specifically focusing on specialty and..
Pharvaris N.V. (NASDAQ: PHVS), a pioneering entity in the biotechnology industry, stands out in the healthcare sector with its innovative approach toward treating rare diseases such..
